Media coverage
33
Media coverage
Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 As A Monotherapy Or In Combination With Pembrolizumab In Metastatic Breast Cancer At The 2021 San Antonio Breast Cancer Symposium® Media name/outlet TheStreet.com Country/Territory United States Date 12/10/21 URL https://www.thestreet.com/press-releases/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-as-a-monotherapy-or-in-combination-with-pembrolizumab-in-metastatic-breast-cancer-at-the-2021-san-antonio-breast-cancer-symposium-reg-15858156 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium®' Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 12/10/21 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Morningstar.com Country/Territory United States Date 12/10/21 URL https://www.morningstar.com/news/pr-newswire/20211210ny03333/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-as-a-monotherapy-or-in-combination-with-pembrolizumab-in-metastatic-breast-cancer-at-the-2021-san-antonio-breast-cancer-symposium Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium®; In a Highly Refractory Population the Diseas Media name/outlet PR Newswire Country/Territory United States Date 12/10/21 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer S Media name/outlet Street Insider Country/Territory United States Date 12/10/21 URL https://www.streetinsider.com/Press+Releases/Intensity+Therapeutics+Reports+Promising+Early+Efficacy+Results+Using+INT230-6+as+a+Monotherapy+or+in+Combination+with+Pembrolizumab+in+Metastatic+Breast+Cancer+at+the+2021+San+Antonio+Breast+Cancer+S/19335806.html Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet BioSpace Country/Territory United States Date 12/10/21 URL https://www.biospace.com/article/releases/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-as-a-monotherapy-or-in-combination-with-pembrolizumab-in-metastatic-breast-cancer-at-the-2021-san-antonio-breast-cancer-symposium-/?s=89 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Canc... Media name/outlet Finanzen.net Country/Territory Germany Date 12/10/21 URL https://www.finanzen.net/nachricht/aktien/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-as-a-monotherapy-or-in-combination-with-pembrolizumab-in-metastatic-breast-cancer-at-the-2021-san-antonio-breast-canc-10832453 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Yahoo! News Country/Territory United States Date 12/10/21 URL https://www.yahoo.com/now/intensity-therapeutics-reports-promising-early-130100736.html Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Yahoo! Finance Country/Territory United States Date 12/10/21 URL https://finance.yahoo.com/news/intensity-therapeutics-reports-promising-early-130100736.html Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet ADVFN US Country/Territory United States Date 12/10/21 URL https://www.advfn.com/p.php?pid=nmona&article=86780947 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet ProfitQuotes.com Country/Territory United States Date 12/10/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202112202112100801PR_NEWS_USPR_____NY03333 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet TickerTech.com Country/Territory United States Date 12/10/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202112202112100801PR_NEWS_USPR_____NY03333 Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Spoke.com Country/Territory United States Date 12/10/21 URL https://www.spoke.com/press_releases/61b35038f8f2df4cf40075bb Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet KCBD Country/Territory United States Date 12/10/21 URL www.kcbd.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WALB 10 Country/Territory Georgia Date 12/10/21 URL www.walb.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WIBW Country/Territory United States Date 12/10/21 URL https://www.wibw.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WBKO Country/Territory United States Date 12/10/21 URL https://www.wbko.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet NewsChannel 10 Country/Territory United States Date 12/10/21 URL https://www.newschannel10.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WTOK-TV Country/Territory United States Date 12/10/21 URL https://www.wtok.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WOWT Country/Territory United States Date 12/10/21 URL https://www.wowt.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Kgns.tv Country/Territory United States Date 12/10/21 URL https://www.kgns.tv/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet KWTX Country/Territory United States Date 12/10/21 URL https://www.kwtx.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet KPLC TV Country/Territory United States Date 12/10/21 URL www.kplctv.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Upper Michigans Source Country/Territory United States Date 12/10/21 URL https://www.uppermichiganssource.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet My Sun Coast Country/Territory United States Date 12/10/21 URL www.mysuncoast.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet NBC12 Online Country/Territory United States Date 12/10/21 URL www.nbc12.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Hawaii News Now Country/Territory United States Date 12/10/21 URL www.hawaiinewsnow.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WRDW Country/Territory United States Date 12/10/21 URL https://www.wrdw.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet KOLO TV Reno Country/Territory United States Date 12/10/21 URL https://www.kolotv.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Webcenter 11 Country/Territory United States Date 12/10/21 URL https://www.webcenterfairbanks.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Wave 3 Country/Territory United States Date 12/10/21 URL www.wave3.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet Fox 19 Country/Territory United States Date 12/10/21 URL www.fox19.com/prnewswire/2021/12/10/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-monotherapy-or-combination-with-pembrolizumab-metastatic-breast-cancer-2021-san-antonio-breast-cancer-symposium/ Persons Anthony J. Olszanski Title Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium® Media name/outlet WFMZ-TV Online Country/Territory United States Date 12/10/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/intensity-therapeutics-reports-promising-early-efficacy-results-using-int230-6-as-a-monotherapy-or-in/article_85e7a882-b1bb-5a04-9e22-75c4a1e542a5.html Persons Anthony J. Olszanski